May 19, 2016
Impact of Reimbursement for Biomarker Testing on Clinical Practice
Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video LibraryDrs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”
Related Videos
July 29, 2015
Introducing New Agents into the Standard of Care
Dr. S. Yosuf Zafar questions how to incorporate new agents into the standard of cancer care as many of these agents are both expensive and only useful for a small segment of patients.
March 31, 2015
Challenge of Sustainable Pricing Model
Alexander Bastian speaks about the need for a sustainable model of pricing as related to cancer treatments and drug development. He talks about indication-based pricing or tumor-based pricing—says that is compelling, but not necessarily possible in the US.